Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05009394
Other study ID # 2021-02346
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 20, 2023
Est. completion date June 2028

Study information

Verified date September 2023
Source Center for Bionics and Pain Research
Contact Emily Pettersen, MSc
Phone +46764026503
Email emily.pettersen@vgregion.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a double-blind randomised controlled trial (RCT) which compares the effectiveness of three surgical techniques for alleviating residual limb pain (RLP), neuroma pain and phantom limb pain (PLP). The three surgical treatments are Targeted Muscles Reinnervation (TMR), Regenerative Peripheral Nerve Interface (RPNI), and an active control (neuroma excision and muscle burying). Patients will be follow-up for 4 years.


Description:

Residual limb pain (RLP), neuroma pain, and phantom limb pain (PLP) can develop after the loss of a body part and fall within the umbrella term postamputation pain. However, the underlaying causes to postamputation pain are diverse and must be addressed accordingly. Surgical treatments for RLP have become a popular approach and have shown great potential for successful outcomes. The two surgical interventions, Targeted Muscle Reinnervation (TMR) and Regenerative Peripheral Nerve Interface (RPNI), are globally used in pain management therapies. This is a multi-centre, double-blind, superiority RCT which takes place at 9 hospitals in 7 countries:the Sahlgrenska University Hospital in Gothenburg, Sweden; the Rizzoli Orthopaedic Institute in Bologna, Italy; the University of Alberta Hospital in Edmonton, Canada; Worker Hospital in Santiago, Chile; the NHS Lothian, NHS Clyde & Greater Glasgow, and NHS Grampian, UK; Dandenong Hospital, Monash Health in Melbourne, Australia; the Northwestern Memorial Hospital in Chicago, USA; the University of Michigan Health System in Ann Arbor, Michigan, USA; and within the Massachusetts General Hospital in Boston, USA. One hundred ten participants will be recruited and randomly assigned to one of three surgical treatments (TMR, RPNI, or control) in an equal allocation ratio (n = 37 per group). Each participant will be followed up short term (1, 3, 6, and 12 months post-surgery) and long term (2 and 4 years post-surgery). After the 12-month follow-up, the study will be unblinded for the evaluator and the participants. If the participants are unsatisfied with the outcome of the treatment, they may request one of the other treatments. In such a case, a medical evaluation and further treatment options will be discussed in consultation with the clinical investigator at the site. The study design is chosen to be able to follow RLP, neuroma pain and PLP intensity before and after surgical treatment as well as to investigate how pain develops up to four years post-surgery. The evaluation methods in the study are based on previously used methods in the literature for RLP-, neuroma- and PLP-related pain research. The questionnaires are previously used in clinical settings.


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date June 2028
Est. primary completion date June 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The participant must have a major limb amputation. - The participant is = 18 years old at the time of consent. - The participant must be in generally good health to undergo a surgical intervention, as per the clinical investigator's opinion. - Time since the last amputation must be over a year at the time of consent. - The participant must have an average residual limb pain score equal or greater than 4 on the Numerical Rating Scale (NRS, 0-10) after the baseline period. - If the participant has been prescribed pharmacological treatments for pain, there must be no variations in dosage (steady consumption) for at least 1 month before the screening visit. - If the participant has been prescribed non-pharmacological treatments for pain, such as spinal cord stimulation, transcutaneous electrical nerve stimulation, and mirror therapy, the treatment must have ended at least 1 month before the screening visit. - The participant must have a stable prosthetic fitting for at least a month before the screening visit. - The participant has a sufficient understanding of the language in which the assessments will be conducted, as per the clinical investigator's opinion. Exclusion Criteria: - Neurological or other conditions that affect nerve regeneration for the nerve to be treated. - Active infection in the residual limb. - Prior RPNI or TMR surgery of the nerve to be treated (with painful neuroma) to address postamputation pain. - Mental disorders (e.g., schizophrenia, paranoia, psychosis, etc.), reluctance, or language difficulties that result in difficulty understanding the meaning of study participation. - Ongoing participation in a clinical study that the clinical investigator deems detrimental to participation in this study.

Study Design


Intervention

Procedure:
Targeted Muscle Reinnervation (TMR)
Surgical procedure used to rewire injured proximal nerves to motor nerves directly innervating an otherwise redundant target muscle.
Regenerative Peripheral Nerve Interface (RPNI)
Surgical procedure where the the nerve is split into fascicles and wrapped in free muscle grafts.
Standard neuroma treatment, neuroma excision, and muscle burying
Surgical procedure where the neuroma is excised and the nerve stump is buried in an adjacent deep muscle.

Locations

Country Name City State
Australia Dandenong Hospital, Monash Health Melbourne
Canada University of Alberta Hospital Edmonton Alberta
Chile Worker Hospital Santiago
Italy Rizzoli Orthopedic Institute Bologna Emilia-Romagna
Sweden Sahlgrenska University Hospital Mölndal Västra Götaland
United Kingdom NHS Lothian, NHS Clyde & Greater Glasgow, and NHS Grampian Edinburgh
United States University of Michigan Health System Ann Arbor Michigan
United States Massachusetts General Hospital Boston Massachusetts
United States Northwestern Memorial Hospital Chicago Illinois

Sponsors (15)

Lead Sponsor Collaborator
Center for Bionics and Pain Research Chalmers University of Technology, Dandenong Hospital, Göteborg University, Hospital del Trabajador de Santiago, Istituto Ortopedico Rizzoli, Massachusetts General Hospital, NHS Grampian, NHS Greater Clyde and Glasgow, NHS Lothian, Northwestern Memorial Hospital, The Bionics Institute of Australia, University of Alberta, University of Michigan, Vastra Gotaland Region

Countries where clinical trial is conducted

United States,  Australia,  Canada,  Chile,  Italy,  Sweden,  United Kingdom, 

References & Publications (8)

Bjorklund KA, Alexander J, Tulchin-Francis K, Yanes NS, Singh S, Valerio I, Klingele K, Scharschmidt T. Targeted Muscle Reinnervation for Limb Amputation to Avoid Neuroma and Phantom Limb Pain in Patients Treated at a Pediatric Hospital. Plast Reconstr Surg Glob Open. 2023 Apr 13;11(4):e4944. doi: 10.1097/GOX.0000000000004944. eCollection 2023 Apr. — View Citation

Chang BL, Mondshine J, Attinger CE, Kleiber GM. Targeted Muscle Reinnervation Improves Pain and Ambulation Outcomes in Highly Comorbid Amputees. Plast Reconstr Surg. 2021 Aug 1;148(2):376-386. doi: 10.1097/PRS.0000000000008153. — View Citation

Dumanian GA, Potter BK, Mioton LM, Ko JH, Cheesborough JE, Souza JM, Ertl WJ, Tintle SM, Nanos GP, Valerio IL, Kuiken TA, Apkarian AV, Porter K, Jordan SW. Targeted Muscle Reinnervation Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized Clinical Trial. Ann Surg. 2019 Aug;270(2):238-246. doi: 10.1097/SLA.0000000000003088. — View Citation

Kubiak CA, Kemp SWP, Cederna PS, Kung TA. Prophylactic Regenerative Peripheral Nerve Interfaces to Prevent Postamputation Pain. Plast Reconstr Surg. 2019 Sep;144(3):421e-430e. doi: 10.1097/PRS.0000000000005922. — View Citation

Pettersen E, Sassu P, Reinholdt C, Dahm P, Rolfson O, Bjorkman A, Innocenti M, Pedrini FA, Breyer JM, Roche A, Hart A, Harrington L, Ladak A, Power H, Hebert J, Ortiz-Catalan M. Surgical treatments for postamputation pain: study protocol for an international, double-blind, randomised controlled trial. Trials. 2023 May 2;24(1):304. doi: 10.1186/s13063-023-07286-0. — View Citation

Souza JM, Cheesborough JE, Ko JH, Cho MS, Kuiken TA, Dumanian GA. Targeted muscle reinnervation: a novel approach to postamputation neuroma pain. Clin Orthop Relat Res. 2014 Oct;472(10):2984-90. doi: 10.1007/s11999-014-3528-7. — View Citation

Valerio IL, Dumanian GA, Jordan SW, Mioton LM, Bowen JB, West JM, Porter K, Ko JH, Souza JM, Potter BK. Preemptive Treatment of Phantom and Residual Limb Pain with Targeted Muscle Reinnervation at the Time of Major Limb Amputation. J Am Coll Surg. 2019 Mar;228(3):217-226. doi: 10.1016/j.jamcollsurg.2018.12.015. Epub 2019 Jan 8. — View Citation

Woo SL, Kung TA, Brown DL, Leonard JA, Kelly BM, Cederna PS. Regenerative Peripheral Nerve Interfaces for the Treatment of Postamputation Neuroma Pain: A Pilot Study. Plast Reconstr Surg Glob Open. 2016 Dec 27;4(12):e1038. doi: 10.1097/GOX.0000000000001038. eCollection 2016 Dec. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Residual limb pain intensity Difference in residual limb pain intensity will be measured by numerical rating scale (NRS, 0-10), where 0 - no pain and 10 - worst imaginable pain, between baseline period and at the 12-month follow-up visit. Baseline to 12-month post-surgery
Secondary Neuroma pain intensity Difference in neuroma pain intensity will be measured by numerical rating scale (NRS, 0-10), where 0 - no pain and 10 - worst imaginable pain, between baseline period and at the 12-month follow-up visit. Baseline to 12-month post-surgery
Secondary Phantom limb pain intensity Difference in phantom limb pain intensity will be measured by numerical rating scale (NRS, 0-10), where 0 - no pain and 10 - worst imaginable pain, between baseline period and at the 12-months follow-up visit. Baseline to12-month post-surgery
See also
  Status Clinical Trial Phase
Completed NCT04060875 - Research Protocol for Karuna Labs Inc.: Safety and Efficacy of Virtual Reality Graded Motor Imagery for Chronic Pain
Active, not recruiting NCT02519907 - Surface Electrical Stimulation for Treatment of Phantom Limb Pain N/A
Completed NCT02281539 - Myoelectrically Controlled Augmented Reality and Gaming for the Treatment of Phantom Limb Pain N/A
Completed NCT01608035 - Sciatic Perineural Versus Stump Catheter for Below Knee Amputation Phase 0
Completed NCT03111277 - MR Guided Focused Ultrasound for Treatment of Neuropathic Pain N/A
Recruiting NCT05188183 - Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response N/A
Active, not recruiting NCT02221934 - Electrical Nerve Block for Amputation Pain N/A
Active, not recruiting NCT03029884 - Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain N/A
Completed NCT04538417 - C-RFA of Residual Limb Neuroma N/A
Completed NCT03317600 - Postamputation Pain: Peripheral Mechanisms N/A
Completed NCT01996254 - Electrical Stimulation for the Treatment of Post-Amputation Pain Using the SPRINT System N/A
Terminated NCT00771862 - Prevention of Phantom Limb and Stump Pain Using Ambulatory Continuous Peripheral Nerve Blocks: A Pilot Study Phase 4
Completed NCT00462566 - The Efficacy of Motor Cortex Stimulation for Pain Control N/A
Completed NCT05684445 - The Effect of Distant Reiki on Pain and Holistic Well-being N/A
Completed NCT02784548 - Virtual Reality for Phantom Limb Pain N/A
Active, not recruiting NCT05915065 - VR to Evaluate Phantom Limb Pain N/A
Completed NCT00797849 - Controlled Study of Farabloc for Chronic Phantom Limb Pain Among Veteran Amputees N/A
Enrolling by invitation NCT05807607 - Study of Lower-limb Phantom Pain Syndrome Using Peripheral Nerve and Spinal Cord Stimulation N/A
Completed NCT03350061 - Prosthesis With Sensations N/A
Active, not recruiting NCT06428123 - Comparison of Efficacy of Mirror Therapy vs Mental Imagery in Reduction of Phantom Limb Pain in AKAP N/A